Adagene
ADAG
#9322
Rank
HK$0.72 B
Marketcap
HK$15.48
Share price
0.00%
Change (1 day)
-1.48%
Change (1 year)

Revenue for Adagene (ADAG)

Revenue in 2024: HK$0.8 Million

According to Adagene's latest financial reports the company's current revenue (TTM ) is HK$0.8 Million. In 2024 the company made a revenue of HK$0.8 Million a decrease over the revenue in the year 2023 that were of HK$0.14 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Adagene from 2018 to 2024

Annual revenue

Year Revenue Change
2024HK$0.8 M-99.43%
2023HK$0.14 B94.9%
2022HK$72.29 M-8.67%
2021HK$79.16 M1351.71%
2020HK$5.45 M46.02%
2019HK$3.73 M-68.24%
2018HK$11.75 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Novocure
NVCR
HK$4.99 B 622,229.56% Jersey
Novavax
NVAX
HK$7.96 B 992,429.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Organovo
ONVO
HK$1.12 M 39.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
HK$0.16 B 21,061.00%๐Ÿ‡ฌ๐Ÿ‡ง UK